Insider trading at Wacker Chemie: Share and price in focus!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Insider trades at Wacker Chemie: Board acquisitions and price reactions in focus – current developments and market data.

Insider trading at Wacker Chemie: Share and price in focus!

On May 13, 2025, the supervisory authorities were informed of an insider trade at WACKER CHEMIE AG. The transactions occurred on May 9, 2025, when Dr. Christian Kirsten, board member of the company, acquired 4,280 shares at a price of 65.70 euros per share. Also Dr. Tobias Ohler, another executive, participated in the purchases by purchasing 4,100 shares at the same price. On that day, WACKER CHEMIE shares recorded losses and fell by 2.10 percent to 64.20 euros in FSE trading.

The insider deal was published on May 12, 2025. Interestingly, the share price rose by 1.10 percent to 66.05 euros by the end of trading on the same day. A total of 223 WACKER CHEMIE shares changed hands that day. The company's current market value is 3.20 billion euros, with 49,677,984 shares in free float.

About WACKER CHEMIE AG

Wacker Chemie AG, founded in 1914 by Alexander Wacker, is a German multinational chemical company with a wide range of products. The company produces materials that have applications in various global industries, particularly in silicones, polymers and life sciences. The product range includes, among other things, silicone rubber, polymer powder and chemical materials such as polysilicon and wafers for the semiconductor industry.

The company's products are used in several sectors, including construction, automotive, paints, textiles and paper. WACKER has more than 25 production facilities in Europe, Asia and the Americas, with products sold in over 100 countries.

Strategic direction and sustainability

Wacker Chemie AG is divided into five business areas: Wacker Silicones, Wacker Polysilicon, Wacker Polymers, Wacker Biosolutions and Siltronic. To strengthen its presence in North America, the company has established a new headquarters in Ann Arbor, Michigan. WACKER is also investing in expanding pharmaceutical contract development and manufacturing capabilities, including a new plasmid DNA manufacturing facility in San Diego, California.

A central element of the company's strategy is the commitment to sustainable solutions and environmental responsibility. Wacker Chemie is listed on the Frankfurt Stock Exchange and is headquartered in Munich, Germany.

For more information on insider transactions and their impact on the stock, please visit the finance.net and insider-alarm.de.